Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:4094932.
doi: 10.1155/2016/4094932. Epub 2016 Apr 14.

Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification

Affiliations

Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification

Michelle L Grant et al. Can J Infect Dis Med Microbiol. 2016.

Abstract

Becton Dickinson Phoenix Yeast ID Panel was compared to the Remel RapID Yeast Plus System using 150 recent clinical yeast isolates and the API 20C AUX system to resolve discrepant results. The concordance rate between the Yeast ID Panel and the RapID Yeast Plus System (without arbitration) was 93.3% with 97.3% (146/150) and 95.3% (143/150) of the isolates correctly identified by the Becton Dickinson Phoenix and the Remel RapID, respectively, with arbitration.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Zilberberg M. D., Shorr A. F., Kollef M. H. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000–2005. Emerging Infectious Diseases. 2008;14(11):1756–1758. doi: 10.3201/eid1411.080337. - DOI - PMC - PubMed
    1. Wisplinghoff H., Bischoff T., Tallent S. M., Seifert H., Wenzel R. P., Edmond M. B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases. 2004;39(3):309–317. doi: 10.1086/421946. - DOI - PubMed
    1. Pfaller M. A., Diekema D. J. Epidemiology of invasive mycoses in North America. Critical Reviews in Microbiology. 2010;36(1):1–53. doi: 10.3109/10408410903241444. - DOI - PubMed
    1. Horn D. L., Neofytos D., Anaissie E. J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clinical Infectious Diseases. 2009;48(12):1695–1703. doi: 10.1086/599039. - DOI - PubMed
    1. Hope W., Morton A., Eisen D. P. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. Journal of Hospital Infection. 2002;50(1):56–65. doi: 10.1053/jhin.2001.1131. - DOI - PubMed

LinkOut - more resources